POSTED BY STEPHANIE CAIRD | 5 SEPTEMBER 2024 The EU AI Act and its application to medtech The EU AI Act introduces a cross-cutting regulatory regime for AI-based innovations. What will this mean for the medtech industry? Read more Share this article Bookmark this page 3 min read medical device medical devices
POSTED BY ISABEL TEARE | 29 AUGUST 2024 Industry response to the NHS England/NICE medtech evaluation framework Industry response provided by techUK's Life Sciences Working group to proposals from NHS England and NICE for a new integrated, rules-based medical technology (medtech) pathway. Share this article Bookmark this page 2 min read
POSTED BY ISABEL TEARE | 7 AUGUST 2024 Life sciences sector response to a change of government in the UK The new UK government's proposals to promote and strengthen the life sciences sector is welcomed, and challenged to take the necessary steps to improve investment and productivity. Share this article Bookmark this page 3 min read
POSTED BY KATE NEWMAN | 25 JULY 2024 Competition law issues in the life sciences sector: labour markets Share this article Bookmark this page 3 min read
POSTED BY KATRINA ANDERSON | 3 JULY 2024 Developing a regulatory regime for gene-edited food and what this means for industry The implementation of gene editing technology across different sectors is bringing rapid advances. Innovation in food and feed is an important application, with potential for addressing climate change and providing nutritional benefits. However, highly variable regulation presents difficulties for innovators. Share this article Bookmark this page 4 min read
POSTED BY HUGH THOMPSON | 20 JUNE 2024 SPC protection for second medical uses – hope on the horizon? In this blog, Hugh Thompson discusses the potential for the Court of Appeal to review existing law on SPCs which can extend patent protection for a pharmaceutical product in certain circumstances. Share this article Bookmark this page 3 min read
POSTED BY ISABEL TEARE | 13 JUNE 2024 Drafting for disaster – a research project gone wrong Drafting life science research agreements requires care over limitations and exclusions of liability, as well as managing project progress, as a recent dispute demonstrates. Share this article Bookmark this page 4 min read
POSTED BY ISABEL TEARE | 31 MAY 2024 Developing consistent and transparent medtech evaluation NHS England and NICE are developing a more rigorous and transparent pathway for the evaluation of medtech innovations. Share this article Bookmark this page 2 min read
POSTED BY ISABEL TEARE | 28 MAY 2024 A testbed for medical device AI: the MHRA’s AI Airlock The MHRA is establishing a regulatory sandbox for medical device AI to promote swift and effective regulation in this fast-moving field. Share this article Bookmark this page 2 min read
POSTED BY ISABEL TEARE | 17 MAY 2024 How to be clear about royalty payments in a pharmaceutical licensing transaction A recent Court of Appeal case looks at how to draft royalty clauses in a pharmaceutical patent licence, where claim scope and validity may be uncertain, and the product at an early stage of development. Share this article Bookmark this page 4 min read
Subscribe Receive blog alerts via email from our leading team of legal experts Register Visitor Login